You are here
Moderna's Omicron-specific booster could start clinical trials early next year
Primary tabs
Mon, 2021-12-20 20:09 — mike kraft
Moderna's Omicron-specific booster could start clinical trials early next year Biotechnology company Moderna continues to work on developing Covid-19 boosters that specifically target certain variants, including Delta and Omicron, Dr. Stephen Hoge, president of the company, said Monday. CNN
...
"We're going to continue to advance an Omicron-specific booster into clinical trials in early 2022," Hoge said during a company conference call.
For now, Moderna plans to focus its "immediate efforts" around Omicron on advancing the current vaccine that is already available, Hoge said.
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments